ESC 365 - Introduction - New frontiers in cholesterol management in high CV risk patients.

Introduction - New frontiers in cholesterol management in high CV risk patients.

Session: New frontiers in cholesterol management in high cardiovascular risk patients

Topic: Primary cardiovascular prevention: interventions and outcomes

Speaker: Professor D. Bhatt (New York City, US)

Sponsored by Sanofi Regeneron

Event: ESC CONGRESS 2014

Add to my library

About the speaker

Professor Deepak Bhatt

Icahn School of Medicine at Mount Sinai, New York City (United States of America)

52 presentations

15 followers

5 more presentations in this session

How low should LDL-C be lowered? All that matters is how you lower it.

Speaker: Doctor J. Robinson (Iowa, US)

How low should LDL-C be lowered? All that matters is how low you lower it.

Speaker: Professor K. Ray (London, GB)

How might PCSK9 inhibition change this debate?

Speaker: Doctor S. Goodman (Toronto, CA)

Panel discussion - New frontiers in cholesterol management in high CV risk patients.

Concluding remarks - New frontiers in cholesterol management in high CV risk patients.

Speaker: Professor J. Zamorano Gomez (Madrid, ES)

Access the full session

New frontiers in cholesterol management in high cardiovascular risk patients

Speakers: Professor D. Bhatt, Doctor J. Robinson, Professor K. Ray, Doctor S. Goodman, Professor J. Zamorano Gomez

About the event

ESC CONGRESS 2014

30 August - 3 September 2014

Sessions Presentations

ESC 365 is supported by

novartis

Explore sponsored resources

novartis

Explore sponsored resources